melphalan zentiva 50 mg prášok a rozpúšťadlo na injekčný/infúzny roztok
zentiva k.s., Česká republika - melfalán - 44 - cytostatica
rhesonativ
octapharma (ip) sprl, belgicko - Ľudský imunoglobulín anti-d (rh) - 59 - immunopraeparata
rhesonativ 750 iu/ml
octapharma (ip) sprl, belgicko - Ľudský imunoglobulín anti-d (rh) - 59 - immunopraeparata
gammanorm 165 mg/ ml
octapharma (ip) sprl, belgicko - normálne ľudské imunoglobulíny na extravenózne použitie - 59 - immunopraeparata
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
meropeném steriscience 1 000 mg prášok na injekčný/infúzny roztok
steriscience b.v., holandsko - meropeném - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
meropeném steriscience 500 mg prášok na injekčný/infúzny roztok
steriscience b.v., holandsko - meropeném - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
cytotect 100 u/ml infúzny roztok
biotest pharma gmbh, nemecko - Ľudský imunoglobulín proti cytomegalovírusovej infekcii - 59 - immunopraeparata
unasyn p.o.s. 250 mg/5 ml
pfizer europe ma eeig, belgicko - sultamicilín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)